Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
about
The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.Bifunctional crosslinking ligands for transthyretinPopulation diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis.Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathyTransthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Transthyretin familial amyloid polyneuropathy: an update.Series of rare lung diseases mimicking imaging patterns of common diffuse parenchymal lung diseases.
P2860
Q36097190-A3D8C8F7-B35F-4EEF-8603-9DCAB1ED9037Q36122263-095CE59D-1F78-445A-8540-605E8AB3830DQ36320893-A7C7876A-1BED-4903-8C8E-19CDCCD48DE6Q37713229-7E0AD370-9D30-4322-8430-C72786717EA3Q38325612-3490609D-9CE7-4386-82B1-B7A43D1A5AEDQ38614967-E69A5BC7-AAA3-43BD-9176-285E1FE78179Q38708201-6BE5DFCD-44C1-49FA-95E5-80C8B939633CQ38720600-9086815E-B97A-4B71-9BE8-B87C5171E987Q38792184-5EA3C919-A976-4EC0-816C-575D264EB4BEQ41106725-A29753B3-E7D3-44EB-A6A2-496F130E7629Q47561760-7C70EA5F-AF5E-4F6D-9077-EB4A7029DFC5Q47562649-FDD977B3-471E-4D1B-8323-09E1A664D440Q55296249-217D0327-FDCC-4034-9908-BF2909E6297E
P2860
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@ast
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@en
type
label
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@ast
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@en
prefLabel
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@ast
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@en
P2093
P2860
P1433
P1476
Safety and efficacy of long-te ...... nsthyretin (ATTR) amyloidosis.
@en
P2093
Jun Koyama
Shu-ichi Ikeda
Yoshiki Sekijima
P2860
P356
10.3109/13506129.2014.997872
P577
2015-05-27T00:00:00Z